Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Tadalafil and Finasteride may help treat aggressive melanoma.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Imatinib can cause hair loss due to lichen planopilaris.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

A3B5 can reduce skin pigmentation and slow melanoma growth.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Ruxolitinib cream may help treat severe hair loss in children.

Janus kinase inhibitors may help treat lichen planopilaris.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Apremilast shows promise for several skin conditions but needs more research.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.